Lawyers for litigation

Novartis AG v Pharmacor PL [2025] FCAFC 33

Novartis AG v Pharmacor PL [2025] FCAFC 33

PATENTS – infringement – standard patent for a pharmaceutical composition containing certain active pharmaceutical ingredients – claim construction – whether primary judge erred in construction of claim as not including a pharmaceutical composition where the active pharmaceutical ingredient is in the form of a complex in which the ions are associated by non-covalent bonds – no error shown PATENTS – extension of patent term – appeal against primary judge’s finding that the extension of term was not validly granted – s 70 Patents Act 1990 (Cth) – no error shown


Related cases about Patent Infringement

  • AstraZeneca AB v Pharmacor Pty Ltd [2026] FCA 88

    PATENTS – patent entitled “C-aryl glucoside SGLT2 inhibitors and method” which relates to the chemical compound ‘dapagliflozin’– consideration of principles relating to selection patents and whether they form part of Australian law PRACTICE AND PROCEDURE – patents – interlocutory injunction application to restrain launch of generic products prior to expiry of term of patent –…

  • Janssen Pharmaceutica NV v Juno Pharmaceuticals Pty Ltd [2025] FCA 1538

    PRACTICE AND PROCEDURE – patents – interlocutory injunction application – prime facie case – infringement – validity of patent – inventive step – false suggestion – balance of convenience – application granted PATENTS – paliperidone palmitate long-acting injectable – infringement – regimen claim – method of treatment claim – Swiss claim – authorisation or participation…

  • Vehicle Monitoring Systems PL v SARB Management Group PL (No 13) [2025] FCA 1078

    PATENTS – infringement – Patents Act 1990 (Cth) s 122(1) – election between damages and account of profits – time of election – whether applicant should be compelled to make election before evidence is filed – balance between informed choice and efficient conduct of case – applicant ordered to make election within 21 days.

Send this to a friend